Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A comprehensive analysis of the efficacy and effectiveness of COVID-19 vaccines
Xiao‐Feng He, Jiao Su, Yunan Ma, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults
Edward E. Walsh, Gonzalo Pérez Marc, Agnieszka Zareba, et al.
New England Journal of Medicine (2023) Vol. 388, Iss. 16, pp. 1465-1477
Closed Access | Times Cited: 390
Respiratory Syncytial Virus Infection in Older Adults: An Update
Franco Alfano, Tommaso Bigoni, Francesco Paolo Caggiano, et al.
Drugs & Aging (2024) Vol. 41, Iss. 6, pp. 487-505
Open Access | Times Cited: 19
Insights for COVID-19 in 2023
Francisco Javier Martín‐Sánchez, Manuel Martínez‐Sellés, José Molero, et al.
Revista Española de Quimioterapia (2022) Vol. 36, Iss. 2, pp. 114-124
Open Access | Times Cited: 70
COVID-19 Vaccines over Three Years after the Outbreak of the COVID-19 Epidemic
Aleksandra Anna Zasada, Aniela Darlińska, Aldona Wiatrzyk, et al.
Viruses (2023) Vol. 15, Iss. 9, pp. 1786-1786
Open Access | Times Cited: 23
An overview of viral mutagenesis and the impact on pathogenesis of SARS-CoV-2 variants
Muhammad Zafar Irshad Khan, Adila Nazli, Hawaa Al-furas, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17
Self‐Reported Adverse Events Following COVID‐19 Vaccination Among Medical Sciences Students After a Symptomatology Training Program: A Cross‐Sectional Study
Taraneh Tavanaei Tamanaei, Mohammad Bagher Oghazian, Mehran Mojtabaee, et al.
Health Science Reports (2025) Vol. 8, Iss. 3
Open Access
Impact on the time elapsed since SARS-CoV-2 infection, vaccination history, and number of doses, on protection against reinfection
Laura Sánchez-de Prada, Ana María Martínez-García, Belén González-Fernández, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Difference of clinical characteristics in patients with reinfection and primary infection variants of SARS-CoV-2: a retrospective study in China
Chaochao Qiu, Xiaoqing Lin, Qiang Zhang, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
SARS-CoV-2 Neutralizing Antibodies in Mexican Population: A Five Vaccine Comparison
Fernando Alcorta-Núñez, Diana Cristina Pérez-Ibave, Carlos Horacio Burciaga-Flores, et al.
Diagnostics (2023) Vol. 13, Iss. 6, pp. 1194-1194
Open Access | Times Cited: 5
Unravelling humoral immunity in SARS-CoV-2: Insights from infection and vaccination
Nouhaila Najimi, Chaimae Kadi, Noureddine Elmtili, et al.
Human Antibodies (2024) Vol. 32, Iss. 3, pp. 85-106
Closed Access | Times Cited: 1
A longitudinal mixed effects model for assessing mortality trends during vaccine rollout
Qin Shao, Mounika Polavarapu, L Small, et al.
Healthcare Analytics (2024) Vol. 6, pp. 100347-100347
Open Access | Times Cited: 1
RNA replication-independent, DNA linearization-dependent expression of reporter genes from a SARS-CoV-2 replicon-encoding DNA in human cells
Ronja Friedhoff, Ghada Elfayres, Natacha Mérindol, et al.
PLoS ONE (2024) Vol. 19, Iss. 8, pp. e0300491-e0300491
Open Access | Times Cited: 1
Evaluation of the COVID-19 vaccine effectiveness on the outcomes of COVID 19 disease in Iran: a test-negative case-control study
Fatemeh Khosravi Shadmani, Ghobad Moradi, Mohammadreza Naghipour, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Knowledge, attitude, intentional practice and individualized determinants of COVID‐19 vaccine uptake among adults: A cross‐sectional study in Tanzania
Amimu A. Nassoro, Walter C. Millanzi, Patricia Z. Herman
Nursing Open (2024) Vol. 11, Iss. 5
Open Access | Times Cited: 1
The effectiveness of booster vaccination of inactivated COVID-19 vaccines against susceptibility, infectiousness, and transmission of omicron BA.2 variant: a retrospective cohort study in Shenzhen, China
Yuxue Liao, Jiao Su, Jieru Zhao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
The time is now for committed and comprehensive action to attain more broadly protective coronavirus vaccines: The coronavirus vaccines R&D roadmap
Margaret Hamburg, Gregory A. Poland
Vaccine (2023) Vol. 41, Iss. 16, pp. 2645-2647
Open Access | Times Cited: 3
Rapidly Progressive Glomerulonephritis: A COVID-19 Case Report
Tahir Ali, Jasmit Walia, Timothy Daly, et al.
Cureus (2023)
Open Access | Times Cited: 3
Pediatric COVID-19 Vaccination in the Inpatient Setting
Margaret Rush, Cleopatra Hyman, Alexandra B. Yonts, et al.
Hospital Pediatrics (2023) Vol. 13, Iss. 11, pp. e329-e332
Closed Access | Times Cited: 3
The future for COVID-19 vaccines: public health assessment and perspectives based on scientific evidence
Massimo Andreoni, Paolo Bonanni, Andrea Cossarizza, et al.
Infezioni in Medicina (2023) Vol. 31, Iss. 1
Open Access | Times Cited: 2
Chinese expert consensus on the management of patients with hematologic malignancies infected with SARS-CoV-2
Jun Wang, Liang Shao, Jing Liang, et al.
Journal of Cancer Research and Therapeutics (2023) Vol. 19, Iss. 6, pp. 1495-1500
Open Access | Times Cited: 2
COVID-19 Preoperative Blood Tests : What Do They Tell Us About COVID-19 Vaccines?
Laurent Dupoirieux
Medicine and Clinical Science (2023) Vol. 5, Iss. 2
Open Access | Times Cited: 1
Immunogenicity and reactogenicity of inactivated SARS-CoV-2 vaccines in healthy adults
Yufei Wu, Ping Huang, Mingjie Xu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 1
Vaccination status and outcomes in critical COVID-19 patients
P.N. Costa, João Oliveira Pereira, Aurea Higón Cañigral, et al.
Jornal Brasileiro de Pneumologia (2024), pp. e20230116-e20230116
Open Access
T7 RNA polymerase-independent expression of reporter genes from a T7 promoter-driven SARS-CoV-2 replicon-encoding DNA in human cells
Ronja Friedhoff, Ghada Elfayres, Natacha Mérindol, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Blood collection tube and anticoagulant influence on SARS-CoV-2 antibody and avidity levels
Nicholas C. Castro, Jimmie Bullock, Katarzyna Haynesworth, et al.
Heliyon (2024) Vol. 10, Iss. 14, pp. e34449-e34449
Open Access
Page 1 - Next Page

Scroll to top